Literature DB >> 1384967

Loss of keratin expression in anaplastic carcinoma cells due to posttranscriptional down-regulation acting in trans.

M L Paine1, J R Gibbins, K E Chew, A Demetriou, R F Kefford.   

Abstract

Rat keratin K5 and vimentin complementary DNAs have been isolated, identified, and used to study keratin and vimentin expression as markers for cell differentiation. Isologous rat neoplastic epithelial cell lines used were based on a clonal benign epithelial line (A5P/B10) and a clonal anaplastic malignant derivative line (T952/F7). Stable cytoplasmic mRNA was detected for keratin but not vimentin in the benign cells. The anaplastic derivative cells expressed vimentin but showed a 1000-fold reduction in the keratin message, which nuclear run-on assays identified as being due to posttranscriptional down-regulation. An identical pattern of posttranscriptional down-regulation was found in independent malignant somatic cell hybrids of the benign and anaplastic cells. trans-acting regulatory mechanisms implicated in posttranscriptional (pretranslational) keratin down-regulation in these anaplastic malignant cells may play a role in the apparent loss of differentiation evident in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384967

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.

Authors:  P Meleady; M Clynes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

3.  Phenotypic analysis of human fetal renal cells transformed by the SV40 large T antigen.

Authors:  S Zannoni; F Boudreau; C Asselin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

4.  Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.

Authors:  G Conforti; A M Codegoni; E Scanziani; E Dolfini; T Dasdia; M Calza; M Caniatti; M Broggini
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

5.  Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.

Authors:  B R Henderson
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.